Feb 13, 2020
2020-2025 Human Papillomavirus (HPV) Testing Industry Report - Roche, Qiagen, Hologic and Abbott are Dominating the Competition
Feb 12, 2020
The Global Human Papillomavirus (HPV) Testing Market to Reach Revenues of Over $1 Billion During the Period 2020 -2025 - Market Research by Arizton
Feb 10, 2020
Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)
Feb 07, 2020
Disease Analysis: Human Papillomavirus (HPV) Vaccines
Feb 03, 2020
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
Jan 30, 2020
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Jan 29, 2020
VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration
Jan 15, 2020
Inovio Welcomes Biotech Leader to its Board of Directors
Jan 14, 2020
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia
Jan 06, 2020
Inovio Provides Update on Clinical Program Plans for 2020
Nov 25, 2019
Inovio Pharmaceuticals to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
Nov 15, 2019
Inovio Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference
Nov 12, 2019
Inovio Pharmaceuticals Reports 2019 Third Quarter Financial Results
Nov 12, 2019
BD Submits Pre-Market Approval Supplement to FDA for BD Onclarity(TM) HPV Test with Extended Genotyping Capabilities
Nov 07, 2019
Civis Analytics Kicks off "Voice of the Patient" Research Series with New Studies on Telehealth and HPV Vaccination
Oct 29, 2019
Inovio Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019
Oct 14, 2019
ISA Pharmaceuticals B.V. Receives EUR 20m Loan From European Investment Bank
Sep 18, 2019
If you could get a vaccination that would prevent cancer - would you?
Sep 03, 2019
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 22, 2019
Global Cervical Cancer Vaccines Market to Surpass US$ 6 Billion by 2026